Eloxx Pharmaceuticals, Inc.
ELOX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $13,216 | $8,606 | $5,438 | $3,943 |
| - Cash | $4,775 | $4,331 | $4,904 | $19,207 |
| + Debt | $5,758 | $6,106 | $6,236 | $13,384 |
| Enterprise Value | $14,199 | $10,381 | $6,770 | -$1,880 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,169 | -$3,926 | -$5,559 | -$5,560 |
| % Margin | – | – | – | – |
| Net Income | -$3,592 | -$4,341 | -$6,230 | -$6,319 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.31 | -1.96 | -2.88 | -2.92 |
| % Growth | 33.2% | 31.9% | 1.4% | – |
| Operating Cash Flow | -$3,450 | -$2,066 | -$6,814 | -$5,661 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,450 | -$2,066 | -$6,814 | -$5,661 |